Long-term expression changes of immune-related genes in prostate cancer after radiotherapy.
Long-term expression changes of immune-related genes in prostate cancer after radiotherapy.
复制标题
DOI:
10.1007/s00262-021-03036-w
复制
发表时间:
2022-04
期刊:
影响因子:
--
通讯作者:
Coleman CN
中科院分区:
文献类型:
--
作者:
Eke I;Aryankalayil MJ;Bylicky MA;Sandfort V;Vanpouille-Box C;Nandagopal S;Graves EE;Giaccia AJ;Coleman CN
The expression of immune-related genes in cancer cells can alter the anti-tumor immune response and thereby impact patient outcomes. Radiotherapy has been shown to modulate immune-related genes dependent on the fractionation regimen. To identify long-term changes in gene expression after irradiation, PC3 (p53 deleted) and LNCaP (p53 wildtype) prostate cancer cells were irradiated with either a single dose (SD, 10 Gy) or a fractionated regimen (MF) of 10 fractions (1 Gy per fraction). Whole human genome arrays were used to determine gene expression at 24 h and 2 months after irradiation. Immune pathway activation was analyzed with Ingenuity Pathway Analysis (IPA) software. Additionally, 3D colony formation assays and T-cell cytotoxicity assays were performed. LNCaP had a higher basal expression of immunogenic genes and were more efficiently killed by cytotoxic T-cells compared to PC3. In both cell lines, MF irradiation resulted in an increase of multiple immune-related genes immediately after irradiation, while at 2 months SD irradiation had a more pronounced effect on radiation-induced gene expression. Both immunogenic and immunosuppressive genes were upregulated in the long-term in PC3 cells by a 10 Gy SD irradiation but not in LNCaP. T cell-mediated cytotoxicity was significantly increased in 10 Gy SD PC3 cells compared to the unirradiated control and could be further enhanced by treatment with immune checkpoint inhibitors. Irradiation impacts the expression of immune-related genes in cancer cells in a fractionation-dependent manner. Understanding and targeting these changes may be a promising strategy for primary prostate cancer and recurrent tumors.
登录
查看更多内容
DOI:
10.1158/1541-7786.mcr-18-0232
发表时间:
2018-12
期刊:
Molecular cancer research : MCR
影响因子:
--
作者:
Eke I;Makinde AY;Aryankalayil MJ;Reedy JL;Citrin DE;Chopra S;Ahmed MM;Coleman CN
通讯作者:
Coleman CN
影响因子:
5.7
作者:
Eke I;Makinde AY;Aryankalayil MJ;Sandfort V;Palayoor ST;Rath BH;Liotta L;Pierobon M;Petricoin EF;Brown MF;Stommel JM;Ahmed MM;Coleman CN
通讯作者:
Coleman CN
DOI:
10.1016/j.mrfmmm.2010.12.003
发表时间:
2011-02-10
影响因子:
2.3
作者:
Aypar, Umut;Morgan, William F.;Baulch, Janet E.
通讯作者:
Baulch, Janet E.
影响因子:
82.9
作者:
Formenti SC;Rudqvist NP;Golden E;Cooper B;Wennerberg E;Lhuillier C;Vanpouille-Box C;Friedman K;Ferrari de Andrade L;Wucherpfennig KW;Heguy A;Imai N;Gnjatic S;Emerson RO;Zhou XK;Zhang T;Chachoua A;Demaria S
通讯作者:
Demaria S
影响因子:
--
作者:
Bloom, Jordan E.;McNeel, Douglas G.
通讯作者:
McNeel, Douglas G.